Determinants of R&D Disclosures of Nasdaq-Listed Biotechnology Firms
This study investigates the determinants of discretionary research and development (R&D) disclosures of biotechnology firms listed on the NASDAQ. Our study proposes that firms with higher levels of information asymmetry are more likely to disclose information about R&D than f...
Saved in:
Main Authors: | TAN, Pearl Hock Neo, GAN, Peck-Yen, LOW, Calvin, Chim, Wai-Kay |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2005
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soa_research/76 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
Similar Items
-
An empirical study of voluntary research and development disclosures of biotechnology firms listed on NASDAQ
by: Gan, Peck Yen, et al.
Published: (2008) -
The Information Content of Trades of Inactive Nasdaq Stocks
by: CHEN, Peter, et al.
Published: (2003) -
Voluntary disclosure in the biotechnology industry
by: Pan, Grace Meiyun, et al.
Published: (2008) -
Determinants of Internet Reporting by Chinese Listed Companies
by: TAN, Pearl Hock Neo, et al.
Published: (2004) -
The effect of mandatory ESG disclosure on firms’ going-private decisions
by: HUANG, Ying-Chi
Published: (2024)